CIRC (01763) Subsidiary Releases New Isotope Separation Technology for Advanced Nuclear Medicine and Controlled Nuclear Fusion

Stock News
2025/10/17

CIRC (01763) announced that its subsidiary, Chengdu Nuclear High Technology Isotope Co., Ltd. (Nuclear High Technology), has officially launched a new isotope separation technology based on the fourth-generation "MOF" materials called “Adsorption Catcher.” This innovation aims to inject new momentum into the fields of advanced nuclear medicine and controlled nuclear fusion, paving the way for new industrial development prospects. The “Adsorption Catcher” technology innovatively incorporates fourth-generation "MOF" materials, which were highlighted in the 2025 Nobel Prize in Chemistry, breaking through the inherent framework of traditional isotope separation technologies and achieving "customized design" of separation materials at the molecular scale. The “Adsorption Catcher” technology showcases significant advantages, including "high purity, high efficiency, low cost, and low energy consumption." It has a wide range of applications covering key areas crucial to the national economy, such as nuclear medicine, nuclear fusion, heavy water reactors, and biomedical research. This development will provide core technological support for building a "self-controllable, safe, and stable" isotope supply chain in China, helping to reduce reliance on imported high-end isotopes.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10